Meyka Pro banner
Schwab Fundamental Emerging Markets Large Company Index ETF

Stay Updated with the Latest Schwab Fundamental Emerging Markets Large Company Index ETF FNDE News in Real Time

Find FNDE news now at Meyka AI. Stay informed with the latest Schwab Fundamental Emerging Markets Large Company Index ETF stocks updates, including price news, market analysis, and expert insights.

FNDEAMEX
Financial ServicesAsset Management - Global
$40.39
$0.20(0.49%)
U.S. Market opens in 16h 44m
SHIBUSD Slides 8.2% as RSI Signals Overbought Conditions
📅 in about 5 hours

SHIBUSD Slides 8.2% as RSI Signals Overbought Conditions

Shiba Inu USD fell 8.2% to $4.61e-06 in 24 hours. RSI at 67 and CCI at 430 show overbought momentum despite strong ADX trend.

Read more 12
CPSC Demands Hospital ER Records Without Legal Notice, Privacy Experts Warn July 28
📅 in about 4 hours

CPSC Demands Hospital ER Records Without Legal Notice, Privacy Experts Warn July 28

The CPSC is demanding hospitals share detailed ER records including names and diagnoses with contractor Konza Health, raising privacy and legal authority concerns. The agency skipped required public notice.

Read more 12
Japan Earthquake Kills Multiple at Kumamoto Mall; 19 Still Missing July 29
📅 in about 3 hours

Japan Earthquake Kills Multiple at Kumamoto Mall; 19 Still Missing July 29

A 7.1 magnitude earthquake hit Kumamoto, Japan on July 28, causing a mall explosion that killed multiple people. 19 remain missing at the mall and a paper factory. 300,000 evacuated.

Read more 12
Harvey Norman Copped $35M Fine Over Misleading Ads on July 29
📅 in about 1 hour

Harvey Norman Copped $35M Fine Over Misleading Ads on July 29

Harvey Norman ordered to pay $35 million penalty after Federal Court found its 60-month interest-free ads masked mandatory credit card fees. Latitude Financial pays $20 million. Combined $55 million is ASIC’s record for misleading financial product marketing.

Read more 12
RBA’s Bullock Signals Fourth Rate Hike as Housing Market Softens on July 29
📅 in 6 minutes

RBA’s Bullock Signals Fourth Rate Hike as Housing Market Softens on July 29

RBA Governor Michele Bullock signals potential fourth rate hike in August while acknowledging housing weakness. Underlying inflation sits at 3.6%, above the RBA’s 2-3% target. Markets now price August hike at just 21% probability.

Read more 12
Emirates Flight Diverted to Hangzhou: 373 Passengers Stranded 24 Hours on July 28
📅 1 hour ago

Emirates Flight Diverted to Hangzhou: 373 Passengers Stranded 24 Hours on July 28

Emirates flight EK302 diverted to Hangzhou with 373 passengers stranded 24 hours due to weather, crew limits, missing A380-qualified staff, and technical failure. Air conditioning failed mid-ordeal.

Read more 12
FTSE 100 Rises 0.22% as Markets Recover From Chip Sell-Off, Middle East Risks Persist
📅 3 hours ago

FTSE 100 Rises 0.22% as Markets Recover From Chip Sell-Off, Middle East Risks Persist

On July 28, 2026, the FTSE 100 advanced 0.22%, bouncing back after a sharp global sell-off in semiconductor stocks unsettled investors earlier in the week. Strong corporate earnings and bargain buying helped support the UK’s benchmark index, while tensions in the Middle East continued to keep traders cautious. Investors are weighing encouraging company results against…

Read more 12
10Y Treasury ~4.62% as Oil Slides; Yield Curve Holds Positive Slope (30Y ~5.11%)
📅 4 hours ago

10Y Treasury ~4.62% as Oil Slides; Yield Curve Holds Positive Slope (30Y ~5.11%)

The 10-year Treasury yield eased to roughly 4.62% on July 28, 2026, pulling back from last week’s highs. Brent crude fell to $86.58 a barrel, down 1.54% on the day, as hopes grew for renewed US-Iran talks. The 30-year Treasury yield slipped to 5.111%, while the 2-year fell to 4.301%. Despite the pullback, the Treasury…

Read more 12
FDA Issues Class II Recall for Subpotent Levothyroxine Tablets on July 28
📅 4 hours ago

FDA Issues Class II Recall for Subpotent Levothyroxine Tablets on July 28

Major Pharmaceuticals recalls levothyroxine sodium tablets nationwide due to subpotency. The FDA classified it as a Class II recall on July 17. Affected patients should consult their doctor and return medication to the pharmacy.

Read more 12

FNDE News FAQ